Home Medical Societies & Organizations

Medical Societies & Organizations

SU2C and Lustgarten Award U.S. $ 7 million Grants to Pancreatic Cancer Reserach

The Lustgarten Foundation, America’s largest private funder of pancreatic cancer research and Stand Up To Cancer (SU2C), working together in The Pancreatic Cancer Collective, a strategic initiative and partnership designed to improve cancer patient outcomes, have awarded a total of U.S $ 7 million in first-round "New Therapies Challenge" grants to seven teams of top cancer researchers to explore...

Professional Societies Disclose Their Disclosure Policies, But Why Won’t Some Discuss Them?

Last month I wrote about “How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?” The article dealt with the fallout of Baselga’s failure to disclose millions of dollars he had received from industry, and his subsequent resignation as Memorial Sloan Kettering Cancer Center’s physician-in-chief as well as from a number of corporate boards. The disclosure issue had initially...

Otis Brawley Discusses Life After Leaving the American Cancer Society

When Otis W. Brawley, MD — who had served as the face of the American Cancer Society (ACS) for the past 11 years—resigned earlier this month as the organization’s senior vice president and chief medical and scientific officer to pursue new opportunities at an as-yet-to-be disclosed major university, many members of the cancer community were surprised and shocked. Brawley had...

Gastrointestinal Bleeding Predicts Substantial Increase in Cancer Diagnosis

Late breaking results presented as part of a Clinical Trial Updates from the COMPASS Trial (Cardiovascular OutcoMes for People Using Anticoagulation StrategieS) suggest that bleeding in patients treated with anticoagulants should stimulate a search for cancer. The data was presented at the annual congress if the European Society of Cardiology (ESC) being held August 25 - 29, 2018 in...

Cancer Research Organizations Recommend Changes to Reduce Barriers to Clinical Trial Participation

Two cancer research organizations, the American Society of Clinical Oncology, also known as ASCO® and Friends of Cancer Research have submitted to the U.S. Food and Drug Administration (FDA) recommended language for five guidance documents on ways to broaden eligibility criteria for cancer clinical trials. The recommendations are part of a collaboration between the two organizations designed to broaden eligibility...

Medical Societies Call on Governments to Improve Cancer Services and Reduce Cancer Deaths

Two of the world’s leading organizations for oncology professionals, the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology ( ASCO), issued a joint statement calling upon governments around the globe to renew political commitment to improve cancer services and reduce cancer deaths. In their statement, which was issued on the occasion of the United Nations...

Chemotherapy Extends Life by Nearly Twenty Months for Pancreatic Cancer Patients

In a randomized phase III trial patients with surgically removed pancreatic cancer who received modified FOLFIRINOX (mFOLFIRINOX), a chemotherapy regimen containing four different medicines including oxaliplatin, leucovorin, and irinotecan administered intravenously (IV) at day 1, followed by 5-fluorouracil via continuous IV infusion over 46 hours, for 12 two-week cycles, lived a median of 20 months longer and were cancer-free...

Neoadjuvant Chemoradiotherapy May Help People With Pancreatic Cancer Live Longer

A randomized, phase III trial, called PREOPANC-1, funded in part by the Dutch Cancer Society KWF/Koningin Wilhelmina Fonds, found that people who received chemotherapy with radiation, also known as chemoradiotherapy, before pancreatic cancer surgery had better disease-free survival than those who started their treatment with surgery, which is the current standard of care. In addition, the two-year survival rate...

ESMO Launches Unique Study on the Challenges of Female Medical Oncologists

Results from the ESMO Exploratory Survey on the Challenges of Female Oncologists, a project launched by ESMO President, Martine Piccart, MD, PhD, Professor of Oncology at the Université Libre de Bruxelles (ULB) and Director of Medicine at the Jules Bordet Institute, in Brussels, Belgium, were presented during the ESMO Women for Oncology (W4O) Forum at the 2013 European Cancer...

Transforming Patient Care: ASCO Introduces Electronic Data Sharing Standard for Breast Cancer Treatment

TheAmerican Society of Clinical Oncology (ASCO) is building aground-breaking, knowledge-generating, information technology system calledCancerLinQ™which promises to transform virtually every aspect of clinical research and the care and management of patients with cancer. The new system is designed to advance the potential for many new breakthroughs in cancer care.Over the last 50 to 100 years tremendous progress has been made...

right side

ads

Related articles